Literature DB >> 2424021

Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.

J Tschopp, T E Mollnes.   

Abstract

Complement component C9 contains two distinct cysteine-rich domains exhibiting high sequence resemblance to a domain present in the low density lipoprotein (LDL) receptor and epidermal growth factor precursor, respectively. Antibodies were raised against a peptide corresponding to the most conserved region of the LDL receptor/C9-homology segment. The antibodies were shown by immunoblotting to bind specifically to C9 but also to crossreact with C8 alpha, the alpha subunit of complement component C8. Moreover, a monoclonal antibody to a neoantigen present in polymerized C9 bound to an epitope exposed on C8 within the C5b-8 complex but buried in monomeric C8, suggesting that C8 and C9 undergo similar conformational changes during membrane-attack-complex assembly. Isolated C8 alpha-gamma exhibited the propensity to polymerize in the presence of Zn2+ and urea, as already demonstrated for C9. These data indicate that C8 alpha is closely related, both structurally and functionally, to C9.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424021      PMCID: PMC323704          DOI: 10.1073/pnas.83.12.4223

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Function of subunits within the eighth component of human complement: selective removal of the gamma chain reveals it has no direct role in cytolysis.

Authors:  A Brickner; J M Sodetz
Journal:  Biochemistry       Date:  1984-02-28       Impact factor: 3.162

3.  Immunoaffinity purification of human complement component C9 using monoclonal antibodies.

Authors:  B P Morgan; R A Daw; K Siddle; J P Luzio; A K Campbell
Journal:  J Immunol Methods       Date:  1983-11-25       Impact factor: 2.303

4.  Ultrastructure of the membrane attack complex of complement. Heterogeneity of the complex caused by different degree of C9 polymerization.

Authors:  J Tschopp
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

5.  The ninth component of human complement: purification and physicochemical characterization.

Authors:  G Biesecker; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Formation of transmembrane tubules by spontaneous polymerization of the hydrophilic complement protein C9.

Authors:  J Tschopp; H J Müller-Eberhard; E R Podack
Journal:  Nature       Date:  1982-08-05       Impact factor: 49.962

7.  An amphiphilic structure of the ninth component of human complement. Evidence from analysis of fragments produced by alpha-thrombin.

Authors:  G Biesecker; C Gerard; T E Hugli
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

8.  Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.

Authors:  E R Podack; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

9.  Evidence of direct insertion of terminal complement proteins into cell membrane bilayers during cytolysis. Labeling by a photosensitive membrane probe reveals a major role for the eighth and ninth components.

Authors:  E W Steckel; B E Welbaum; J M Sodetz
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

10.  Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.

Authors:  E R Podack; J Tschoop; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more
  8 in total

1.  Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.

Authors:  R Würzner; H Xu; A Franzke; M Schulze; J H Peters; O Götze
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

2.  The preparation and characterization of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunits.

Authors:  A Abraha; B P Morgan; J P Luzio
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

3.  Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones.

Authors:  C F Catterall; A Lyons; R B Sim; A J Day; T J Harris
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

Review 4.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

5.  Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.

Authors:  L Milis; C A Morris; M C Sheehan; J A Charlesworth; B A Pussell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

Review 6.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

Review 7.  Biofunctionalized targeted nanoparticles for therapeutic applications.

Authors:  Andrew Z Wang; Frank Gu; Liangfang Zhang; Juliana M Chan; Aleksander Radovic-Moreno; Mariam R Shaikh; Omid C Farokhzad
Journal:  Expert Opin Biol Ther       Date:  2008-08       Impact factor: 4.388

Review 8.  Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.

Authors:  Jacob J E Koopman; Mieke F van Essen; Helmut G Rennke; Aiko P J de Vries; Cees van Kooten
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.